Global Cancer Genomic Testing Market Size, Status and Forecast 2024-2031

Report ID: 921946 | Published Date: Oct 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Breast Cancer Genomic Testing
        1.2.3 Lung Cancer Genomic Testing
        1.2.4 Blood Cancer Genomic Testing
        1.2.5 Liver Cancer Genomic Testing
        1.2.6 Stomach Cancer Genomic Testing
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Cancer Genomic Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Diagnostic Laboratories
        1.3.5 Academic and Research Institutes
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Genomic Testing Market Perspective (2016-2027)
    2.2 Cancer Genomic Testing Growth Trends by Regions
        2.2.1 Cancer Genomic Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Genomic Testing Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Genomic Testing Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Genomic Testing Industry Dynamic
        2.3.1 Cancer Genomic Testing Market Trends
        2.3.2 Cancer Genomic Testing Market Drivers
        2.3.3 Cancer Genomic Testing Market Challenges
        2.3.4 Cancer Genomic Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Genomic Testing Players by Revenue
        3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2016-2021)
        3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
    3.4 Global Cancer Genomic Testing Market Concentration Ratio
        3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2020
    3.5 Cancer Genomic Testing Key Players Head office and Area Served
    3.6 Key Players Cancer Genomic Testing Product Solution and Service
    3.7 Date of Enter into Cancer Genomic Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genomic Testing Breakdown Data by Type
    4.1 Global Cancer Genomic Testing Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2022-2027)

5 Cancer Genomic Testing Breakdown Data by Application
    5.1 Global Cancer Genomic Testing Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Genomic Testing Market Size (2016-2027)
    6.2 North America Cancer Genomic Testing Market Size by Type
        6.2.1 North America Cancer Genomic Testing Market Size by Type (2016-2021)
        6.2.2 North America Cancer Genomic Testing Market Size by Type (2022-2027)
        6.2.3 North America Cancer Genomic Testing Market Size by Type (2016-2027)
    6.3 North America Cancer Genomic Testing Market Size by Application
        6.3.1 North America Cancer Genomic Testing Market Size by Application (2016-2021)
        6.3.2 North America Cancer Genomic Testing Market Size by Application (2022-2027)
        6.3.3 North America Cancer Genomic Testing Market Size by Application (2016-2027)
    6.4 North America Cancer Genomic Testing Market Size by Country
        6.4.1 North America Cancer Genomic Testing Market Size by Country (2016-2021)
        6.4.2 North America Cancer Genomic Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Genomic Testing Market Size (2016-2027)
    7.2 Europe Cancer Genomic Testing Market Size by Type
        7.2.1 Europe Cancer Genomic Testing Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Genomic Testing Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Genomic Testing Market Size by Type (2016-2027)
    7.3 Europe Cancer Genomic Testing Market Size by Application
        7.3.1 Europe Cancer Genomic Testing Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Genomic Testing Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Genomic Testing Market Size by Application (2016-2027)
    7.4 Europe Cancer Genomic Testing Market Size by Country
        7.4.1 Europe Cancer Genomic Testing Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Genomic Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Genomic Testing Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Genomic Testing Market Size by Type
        8.2.1 Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Genomic Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Genomic Testing Market Size by Application
        8.3.1 Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Genomic Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Genomic Testing Market Size by Region
        8.4.1 Asia-Pacific Cancer Genomic Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Genomic Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Genomic Testing Market Size (2016-2027)
    9.2 Latin America Cancer Genomic Testing Market Size by Type
        9.2.1 Latin America Cancer Genomic Testing Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Genomic Testing Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Genomic Testing Market Size by Type (2016-2027)
    9.3 Latin America Cancer Genomic Testing Market Size by Application
        9.3.1 Latin America Cancer Genomic Testing Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Genomic Testing Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Genomic Testing Market Size by Application (2016-2027)
    9.4 Latin America Cancer Genomic Testing Market Size by Country
        9.4.1 Latin America Cancer Genomic Testing Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Genomic Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Genomic Testing Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Genomic Testing Market Size by Type
        10.2.1 Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Genomic Testing Market Size by Application
        10.3.1 Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Genomic Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Genomic Testing Market Size by Country
        10.4.1 Middle East & Africa Cancer Genomic Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Myriad Genetics
        11.1.1 Myriad Genetics Company Details
        11.1.2 Myriad Genetics Business Overview
        11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
        11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2016-2021)
        11.1.5 Myriad Genetics Recent Development
    11.2 Centogene AG
        11.2.1 Centogene AG Company Details
        11.2.2 Centogene AG Business Overview
        11.2.3 Centogene AG Cancer Genomic Testing Introduction
        11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2016-2021)
        11.2.5 Centogene AG Recent Development
    11.3 Color Genomics
        11.3.1 Color Genomics Company Details
        11.3.2 Color Genomics Business Overview
        11.3.3 Color Genomics Cancer Genomic Testing Introduction
        11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2016-2021)
        11.3.5 Color Genomics Recent Development
    11.4 Quest Diagnostics
        11.4.1 Quest Diagnostics Company Details
        11.4.2 Quest Diagnostics Business Overview
        11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
        11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2016-2021)
        11.4.5 Quest Diagnostics Recent Development
    11.5 23andMe Inc.
        11.5.1 23andMe Inc. Company Details
        11.5.2 23andMe Inc. Business Overview
        11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
        11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2016-2021)
        11.5.5 23andMe Inc. Recent Development
    11.6 Gene By Gene Ltd.
        11.6.1 Gene By Gene Ltd. Company Details
        11.6.2 Gene By Gene Ltd. Business Overview
        11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
        11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2016-2021)
        11.6.5 Gene By Gene Ltd. Recent Development
    11.7 LabCorp
        11.7.1 LabCorp Company Details
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Cancer Genomic Testing Introduction
        11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2016-2021)
        11.7.5 LabCorp Recent Development
    11.8 Positive Bioscience
        11.8.1 Positive Bioscience Company Details
        11.8.2 Positive Bioscience Business Overview
        11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
        11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2016-2021)
        11.8.5 Positive Bioscience Recent Development
    11.9 Bio-Rad Laboratories
        11.9.1 Bio-Rad Laboratories Company Details
        11.9.2 Bio-Rad Laboratories Business Overview
        11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
        11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2016-2021)
        11.9.5 Bio-Rad Laboratories Recent Development
    11.10 Illumina, Inc.
        11.10.1 Illumina, Inc. Company Details
        11.10.2 Illumina, Inc. Business Overview
        11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
        11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2016-2021)
        11.10.5 Illumina, Inc. Recent Development
    11.11 Agilent Technologies
        11.11.1 Agilent Technologies Company Details
        11.11.2 Agilent Technologies Business Overview
        11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
        11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2016-2021)
        11.11.5 Agilent Technologies Recent Development
    11.12 Thermo Fisher Scientific
        11.12.1 Thermo Fisher Scientific Company Details
        11.12.2 Thermo Fisher Scientific Business Overview
        11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
        11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2016-2021)
        11.12.5 Thermo Fisher Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Breast Cancer Genomic Testing
    Table 3. Key Players of Lung Cancer Genomic Testing
    Table 4. Key Players of Blood Cancer Genomic Testing
    Table 5. Key Players of Liver Cancer Genomic Testing
    Table 6. Key Players of Stomach Cancer Genomic Testing
    Table 7. Key Players of Others
    Table 8. Global Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Cancer Genomic Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Cancer Genomic Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Cancer Genomic Testing Market Share by Regions (2016-2021)
    Table 12. Global Cancer Genomic Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Cancer Genomic Testing Market Share by Regions (2022-2027)
    Table 14. Cancer Genomic Testing Market Trends
    Table 15. Cancer Genomic Testing Market Drivers
    Table 16. Cancer Genomic Testing Market Challenges
    Table 17. Cancer Genomic Testing Market Restraints
    Table 18. Global Cancer Genomic Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Cancer Genomic Testing Market Share by Players (2016-2021)
    Table 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genomic Testing as of 2020)
    Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Cancer Genomic Testing Product Solution and Service
    Table 25. Date of Enter into Cancer Genomic Testing Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2016-2021)
    Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Cancer Genomic Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Cancer Genomic Testing Revenue Market Share by Application (2016-2021)
    Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Cancer Genomic Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Cancer Genomic Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Cancer Genomic Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Cancer Genomic Testing Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Cancer Genomic Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Cancer Genomic Testing Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Cancer Genomic Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Cancer Genomic Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Cancer Genomic Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Myriad Genetics Company Details
    Table 66. Myriad Genetics Business Overview
    Table 67. Myriad Genetics Cancer Genomic Testing Product
    Table 68. Myriad Genetics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 69. Myriad Genetics Recent Development
    Table 70. Centogene AG Company Details
    Table 71. Centogene AG Business Overview
    Table 72. Centogene AG Cancer Genomic Testing Product
    Table 73. Centogene AG Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 74. Centogene AG Recent Development
    Table 75. Color Genomics Company Details
    Table 76. Color Genomics Business Overview
    Table 77. Color Genomics Cancer Genomic Testing Product
    Table 78. Color Genomics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 79. Color Genomics Recent Development
    Table 80. Quest Diagnostics Company Details
    Table 81. Quest Diagnostics Business Overview
    Table 82. Quest Diagnostics Cancer Genomic Testing Product
    Table 83. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 84. Quest Diagnostics Recent Development
    Table 85. 23andMe Inc. Company Details
    Table 86. 23andMe Inc. Business Overview
    Table 87. 23andMe Inc. Cancer Genomic Testing Product
    Table 88. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 89. 23andMe Inc. Recent Development
    Table 90. Gene By Gene Ltd. Company Details
    Table 91. Gene By Gene Ltd. Business Overview
    Table 92. Gene By Gene Ltd. Cancer Genomic Testing Product
    Table 93. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 94. Gene By Gene Ltd. Recent Development
    Table 95. LabCorp Company Details
    Table 96. LabCorp Business Overview
    Table 97. LabCorp Cancer Genomic Testing Product
    Table 98. LabCorp Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 99. LabCorp Recent Development
    Table 100. Positive Bioscience Company Details
    Table 101. Positive Bioscience Business Overview
    Table 102. Positive Bioscience Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 103. Positive Bioscience Recent Development
    Table 104. Bio-Rad Laboratories Company Details
    Table 105. Bio-Rad Laboratories Business Overview
    Table 106. Bio-Rad Laboratories Cancer Genomic Testing Product
    Table 107. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 108. Bio-Rad Laboratories Recent Development
    Table 109. Illumina, Inc. Company Details
    Table 110. Illumina, Inc. Business Overview
    Table 111. Illumina, Inc. Cancer Genomic Testing Product
    Table 112. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 113. Illumina, Inc. Recent Development
    Table 114. Agilent Technologies Company Details
    Table 115. Agilent Technologies Business Overview
    Table 116. Agilent Technologies Cancer Genomic Testing Product
    Table 117. Agilent Technologies Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 118. Agilent Technologies Recent Development
    Table 119. Thermo Fisher Scientific Company Details
    Table 120. Thermo Fisher Scientific Business Overview
    Table 121. Thermo Fisher Scientific Cancer Genomic Testing Product
    Table 122. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2016-2021) & (US$ Million)
    Table 123. Thermo Fisher Scientific Recent Development
    Table 124. Research Programs/Design for This Report
    Table 125. Key Data Information from Secondary Sources
    Table 126. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Genomic Testing Market Share by Type: 2020 VS 2027
    Figure 2. Breast Cancer Genomic Testing Features
    Figure 3. Lung Cancer Genomic Testing Features
    Figure 4. Blood Cancer Genomic Testing Features
    Figure 5. Liver Cancer Genomic Testing Features
    Figure 6. Stomach Cancer Genomic Testing Features
    Figure 7. Others Features
    Figure 8. Global Cancer Genomic Testing Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Diagnostic Laboratories Case Studies
    Figure 12. Academic and Research Institutes Case Studies
    Figure 13. Others Case Studies
    Figure 14. Cancer Genomic Testing Report Years Considered
    Figure 15. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Cancer Genomic Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Cancer Genomic Testing Market Share by Regions: 2020 VS 2027
    Figure 18. Global Cancer Genomic Testing Market Share by Regions (2022-2027)
    Figure 19. Global Cancer Genomic Testing Market Share by Players in 2020
    Figure 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Genomic Testing as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2020
    Figure 22. Global Cancer Genomic Testing Revenue Market Share by Type (2016-2021)
    Figure 23. Global Cancer Genomic Testing Revenue Market Share by Type (2022-2027)
    Figure 24. North America Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Cancer Genomic Testing Market Share by Type (2016-2027)
    Figure 26. North America Cancer Genomic Testing Market Share by Application (2016-2027)
    Figure 27. North America Cancer Genomic Testing Market Share by Country (2016-2027)
    Figure 28. United States Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Cancer Genomic Testing Market Share by Type (2016-2027)
    Figure 32. Europe Cancer Genomic Testing Market Share by Application (2016-2027)
    Figure 33. Europe Cancer Genomic Testing Market Share by Country (2016-2027)
    Figure 34. Germany Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Cancer Genomic Testing Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Cancer Genomic Testing Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Cancer Genomic Testing Market Share by Region (2016-2027)
    Figure 44. China Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Cancer Genomic Testing Market Share by Type (2016-2027)
    Figure 52. Latin America Cancer Genomic Testing Market Share by Application (2016-2027)
    Figure 53. Latin America Cancer Genomic Testing Market Share by Country (2016-2027)
    Figure 54. Mexico Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Cancer Genomic Testing Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Cancer Genomic Testing Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Cancer Genomic Testing Market Share by Country (2016-2027)
    Figure 60. Turkey Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Cancer Genomic Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 64. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 65. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 66. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 67. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 68. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 69. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 70. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 72. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 73. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
Frequently Asked Questions
Cancer Genomic Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Genomic Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Genomic Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports